WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹321 Cr | ₹249 Cr | ₹172 Cr | ₹121 Cr | ₹94 Cr |
What is the latest Total Current Liabilities ratio of WINDLAS BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹321 Cr |
| Mar2025 | ₹249 Cr |
| Mar2024 | ₹172 Cr |
| Mar2023 | ₹121 Cr |
| Mar2022 | ₹94 Cr |
How is Total Current Liabilities of WINDLAS BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹321 Cr | 28.66 | |
| Mar2025 | ₹249 Cr | 45.24 | |
| Mar2024 | ₹172 Cr | 41.66 | |
| Mar2023 | ₹121 Cr | 29.00 | |
| Mar2022 | ₹94 Cr | - | |
Compare Total Current Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,755.2 Cr | 0.7% | 0.3% | -12.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 0.7% |
0.3% |
-12.2% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses